Histopathological Scoring of Activated Stromal Reaction and its Associations with Tumor Molecular Subtypes and Prognosis in High-Grade Serous Ovarian Carcinoma

被引：0
|
作者：
Yuan, Lin [1 ]
Guo, Ruifeng [2 ]
Wang, Chen [3 ]
Huang, Yajue [2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai, Peoples R China
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Coll Med, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1225
引用
收藏
页码：1165 / 1165
页数：1
相关论文
共 50 条
  • [31] Personalising Treatment for High-Grade Serous Ovarian Carcinoma
    Cojocaru, E.
    Parkinson, C. A.
    Brenton, J. D.
    CLINICAL ONCOLOGY, 2018, 30 (08) : 515 - 524
  • [32] Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
    Gross, Amy L.
    Kurman, Robert J.
    Vang, Russell
    Shih, Ie-Ming
    Visvanathan, Kala
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [33] PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer.
    Talhouk, Aline
    George, Joshy
    Wang, Chen
    Goode, Ellen
    Ramus, Susan
    Doherty, Jennifer
    Bowtell, David
    Anglesio, Michael
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 38 - 38
  • [34] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Ibrahim Yalcin
    Hanifi Sahin
    Mustafa Erkan Sari
    Asuman Nihan Haberal
    Eda Adeviye Sahin
    Husnu Celik
    Mehmet Mutlu Meydanli
    Ali Ayhan
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [35] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Yalcin, Ibrahim
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Haberal, Asuman Nihan
    Sahin, Eda Adeviye
    Celik, Husnu
    Meydanli, Mehmet Mutlu
    Ayhan, Ali
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [36] Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma
    Peres, Lauren C.
    Colin-Leitzinger, Christelle
    Sinha, Sweta
    Marks, Jeffrey R.
    Conejo-Garcia, Jose R.
    Alberg, Anthony J.
    Bandera, Elisa V.
    Berchuck, Andrew
    Bondy, Melissa L.
    Christensen, Brock C.
    Cote, Michele L.
    Doherty, Jennifer A.
    Moorman, Patricia G.
    Segura, Carlos Moran
    Nguyen, Jonathan V.
    Peters, Edward S.
    Schwartz, Ann G.
    Terry, Paul D.
    Wilson, Christopher M.
    Fridley, Brooke L.
    Schildkraut, Joellen M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [37] Serous Endometrial Intraepithelial Carcinoma with High-Grade Serous Ovarian Carcinoma: A Synchronous Presentation
    Ramya Yethadka
    Ranjitha Vodigenahalli Nagaraj
    Indian Journal of Gynecologic Oncology, 2024, 22
  • [38] Serous Endometrial Intraepithelial Carcinoma with High-Grade Serous Ovarian Carcinoma: A Synchronous Presentation
    Yethadka, Ramya
    Nagaraj, Ranjitha Vodigenahalli
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
  • [39] The phenotype of tumor-associated macrophages in human high-grade serous ovarian carcinoma
    Larionova, I.
    Kazakova, E. O.
    Iamshchikov, P.
    Rakina, M.
    Kzhyshkowska, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1192 - S1192
  • [40] High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target
    Wang, Hanzhi
    Ye, Feng
    Zhou, Caiyun
    Cheng, Qi
    Chen, Huaizeng
    PLOS ONE, 2021, 16 (02):
12345